0001225208-13-023152.txt : 20131108
0001225208-13-023152.hdr.sgml : 20131108
20131108141337
ACCESSION NUMBER: 0001225208-13-023152
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131108
FILED AS OF DATE: 20131108
DATE AS OF CHANGE: 20131108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000810509
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 311080091
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 425 METRO PLACE NORTH
STREET 2: SUITE 300
CITY: DUBLIN
STATE: OH
ZIP: 43017
BUSINESS PHONE: 6147937500
MAIL ADDRESS:
STREET 1: 425 METRO PLACE NORTH
STREET 2: SUITE 300
CITY: DUBLIN
STATE: OH
ZIP: 43017
FORMER COMPANY:
FORMER CONFORMED NAME: NEOPROBE CORP
DATE OF NAME CHANGE: 19940714
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cope Frederick O
CENTRAL INDEX KEY: 0001456549
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35076
FILM NUMBER: 131203961
MAIL ADDRESS:
STREET 1: 425 METRO PLACE NORTH
CITY: DUBLIN
STATE: OH
ZIP: 43017
4
1
doc4.xml
X0306
4
2013-11-08
0000810509
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
0001456549
Cope Frederick O
425 METRO PLACE NORTH
SUITE 450
DUBLIN
OH
43017
1
SVP
Common Stock
2013-11-08
4
P
0
3500.0000
1.4300
A
90814.0000
D
Common Stock
8637.0000
I
By 401(k)
William J. Kelly, Jr., Attorney-In-Fact
2013-11-08